title: NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.
abstract: Natural Killer (NK) cell education, which requires the engagement of inhibitory NK cell receptors (iNKRs) by their ligands, is important for generating self-tolerant functional NK cells. While the potency of NK cell education is directly related to their functional potential upon stimulation with HLA null cells, the influence of NK cell education on the potency of the antibody dependent cellular cytotoxicity (ADCC) function of NK cells is unclear. ADCC occurs when the Fc portion of an immunoglobulin G antibody bridges the CD16 Fc receptor on NK cells and antigen on target cells, resulting in NK cell activation, cytotoxic granule release, and target cell lysis. We previously reported that education via the KIR3DL1/HLA-Bw4 iNKR/HLA ligand combination supported higher KIR3DL1+ than KIR3DL1- NK cell activation levels but had no impact on ADCC potency measured as the frequency of granzyme B positive (%GrB+) targets generated in an ADCC GranToxiLux assay. A lower frequency of KIR3DL1+ compared to KIR3DL1- NK cells were CD16+, which may in part explain the discrepancy between NK cell activation and target cell effects. Here, we investigated the frequency of CD16+ cells among NK cells expressing other iNKRs. We found that CD16+ cells were significantly more frequent among NK cells negative for the inhibitory KIR (iKIR) KIR2DL1, KIR2DL3, and KIR3DL1 than those positive for any one of these iKIR to the exclusion of the others, making iKIR+ NK cells poorer ADCC effectors than iKIR- NK cells. The education status of these iKIR+ populations had no effect on the frequency of CD16+ cells.
authors.affiliation: Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada.|Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
authors.forename: Gamze
authors.initials: G
authors.lastname: Isitman
authors.affiliation: Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada.|Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Tremblay-McLean
authors.affiliation: Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada.|Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
authors.forename: Irene
authors.initials: I
authors.lastname: Lisovsky
authors.affiliation: Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.|Department of Family Medicine, Université de Montréal, Montreal, Quebec, Canada.
authors.forename: Julie
authors.initials: J
authors.lastname: Bruneau
authors.affiliation: Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada.|Chronic Viral Illness Service, MUHC, Montreal, Quebec, Canada.|Department of Family Medicine, McGill University, Montreal, Quebec, Canada.
authors.forename: Bertrand
authors.initials: B
authors.lastname: Lebouché
authors.affiliation: Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada.|Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.|Chronic Viral Illness Service, MUHC, Montreal, Quebec, Canada.|Division of Hematology, MUHC, Montreal, QC, Canada.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Routy
authors.affiliation: Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada.|Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.|Chronic Viral Illness Service, MUHC, Montreal, Quebec, Canada.|Division of Clinical Immunology, MUHC, Montreal, Quebec, Canada.
authors.forename: Nicole F
authors.initials: NF
authors.lastname: Bernard
mesh_terms: D000920:Antibody-Dependent Cell Cytotoxicity; D002478:Cells, Cultured; D058851:GPI-Linked Proteins / Q000032:analysis / Q000276:immunology; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D017452:Receptors, IgG / Q000032:analysis / Q000276:immunology*; D054342:Receptors, KIR2DL1 / Q000032:analysis / Q000276:immunology*; D054344:Receptors, KIR2DL3 / Q000032:analysis / Q000276:immunology*; D054341:Receptors, KIR3DL1 / Q000032:analysis / Q000276:immunology*
chemical_list: C428200:FCGR3B protein, human; D058851:GPI-Linked Proteins; C093100:KIR2DL1 protein, human; C515078:KIR2DL3 protein, human; C515083:KIR3DL1 protein, human; D017452:Receptors, IgG; D054342:Receptors, KIR2DL1; D054344:Receptors, KIR2DL3; D054341:Receptors, KIR3DL1